Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab. (January 2022)

Record Type:
Journal Article
Title:
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab. (January 2022)
Main Title:
Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab
Authors:
Felten, Renaud
Gallais, Floriane
Schleiss, Cédric
Chatelus, Emmanuel
Javier, Rose-Marie
Pijnenburg, Luc
Sordet, Christelle
Sibilia, Jean
Arnaud, Laurent
Fafi-Kremer, Samira
Gottenberg, Jacques-Eric
Abstract:
Is Part Of:
Lancet. Volume 4:Number 1(2022)
Journal:
Lancet
Issue:
Volume 4:Number 1(2022)
Issue Display:
Volume 4, Issue 1 (2022)
Year:
2022
Volume:
4
Issue:
1
Issue Sort Value:
2022-0004-0001-0000
Page Start:
e13
Page End:
e16
Publication Date:
2022-01
Subjects:
Rheumatology -- periodicals
616.72305
Journal URLs:
https://www.thelancet.com/journals/lanrhe/issues#decade=loi_decade_201 ↗
https://www.sciencedirect.com/journal/the-lancet-rheumatology ↗
http://www.sciencedirect.com/ ↗
DOI:
10.1016/S2665-9913(21)00351-9 ↗
Languages:
English
ISSNs:
2665-9913
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
20301.xml